Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2025年1月17日

• Richard B. Warren,
• Lev Pavlovsky,
• Antonio Costanzo,
• Michael Bukhalo,
• Neil J. Korman,
• Yu-Huei Huang,
• Georgios Kokolakis,
• Andreas Pinter,
• Nadia Ibrahim,
• Yanbing Zheng,
• Leonidas Drogaris,
• Vassilis Stakias,
• Ahmed M. Soliman,
• Simone Rubant,
• Diamant Thaçi